Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

Clinical trials have shown that AS03-adjuvanted H5N1 and A(H1N1)pdm09 vaccines are highly immunogenic, although with an increased reactogenicity profile relative to non-adjuvanted vaccines in terms of the incidence of common injection site and systemic adverse events (AEs). We evaluated pooled safet...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Vaughn, David W, Seifert, Harry, Hepburn, Anne, Dewe, Walthere, Li, Ping, Drame, Mamadou, Cohet, Catherine, Innis, Bruce L, Fries, Louis F
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2014
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443104/
https://ncbi.nlm.nih.gov/pubmed/25483467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.972149
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky